Organicell Regenerative Medicine, Inc. filed its 10-K on Feb 14, 2023 for the period ending Oct 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +7.69% | 0.00% | +9.80% |
18/03 | Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
05/03 | Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.80% | 68.61L | |
+19.13% | 7.17TCr | |
-3.66% | 2.37TCr | |
+8.80% | 900.94Cr | |
+11.24% | 864.08Cr | |
-18.91% | 814.74Cr | |
+16.00% | 533.31Cr | |
+17.83% | 435.48Cr | |
-2.11% | 409.63Cr | |
-1.72% | 394.49Cr |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Organicell Regenerative Medicine, Inc. Auditor Raises 'Going Concern' Doubt